9th annual World Cancer Series
Event: 9th annual World Cancer Series: Europe Date: September [...]
Drugmakers push into radio pharmaceuticals
Dolgin, E. Drugmakers go nuclear, continuing push into radiopharmaceuticals. Nat Biotechnol 39, 647–649 [...]
Asco 2021 justifies Novartis’s radioligand Vision
Evaluate Vantage, Jacob Plieth, June 3, 2021 177Lu-PSMA-617 significantly improves [...]
Nuclear Medicine and Molecular Imaging Week: October 4-10, 2020
October 4-10 2020 is nuclear medicine and molecular imaging week! [...]
First clinical results for PSMA TAT using Ac-225-PSMA-I&T in advanced mCRPC patients
First clinical results for PSMA targeted alpha therapy using 225Ac-PSMA-I&T [...]
IAEA activities on Cu-67, Re-186, Sc-47 Theranostic radionuclides and Radiopharmaceuticals
International Atomic Energy Agency (IAEA) activities on 67Cu, 186Re, 47Sc [...]
The Role of Ga-68-FAPI PET/CT for Malignancies of the Lower GI Tract
The Role of 68Ga-FAPI PET/CT for Patients with Malignancies of [...]
First patients dosed in clinical trial of novel lung and ovarian cancer theranostic
Telix Pharmaceuticals Limited announced that the first two patients have [...]
ProsTIC – The new Centre of Excellence
Congratulations Peter MacCallum Cancer Centre for the launch of The Prostate [...]
TheraP Trial Design in Prostate Cancer
Interesting interview with Pr. Michael Hofman about TheraP Trial Design [...]